331 results on '"Chen, Minhu"'
Search Results
2. Pharmacokinetics, Safety, and Tolerability of Tenapanor in Healthy Chinese and Caucasian Volunteers: A Randomized, Open-Label, Single-Center, Placebo-Controlled Phase 1 Study
3. Milk fat globule-epidermal growth factor 8 (MFGE8) prevents intestinal fibrosis
4. Comparative analysis of [18F]F-FAPI PET/CT, [18F]F-FDG PET/CT and magnetization transfer MR imaging to detect intestinal fibrosis in Crohn’s disease: A prospective animal model and human cohort study
5. Predicting Factors of Long-term Outcome of Gastrointestinal Behçet's Disease: A Chinese Retrospective Study
6. Schaumann bodies deposited along myenteric plexus of the muscularis propria is a unique histopathological feature of Crohn’s disease
7. International clinical practice guideline on the use of traditional Chinese medicine for ulcerative colitis by Board of Specialty Committee of Digestive System Disease of World Federation of Chinese Medicine Societies (2023)
8. Circulating Regulatory T Cells: A Novel Marker Associated with Liver Metastasis and the Treatment Response of Transarterial Embolization in Gastroenteropancreatic Neuroendocrine Tumors
9. Validation of disease severity index for predicting complicated disease in Crohn's disease: A comparison study with Lémann index
10. Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets
11. S288 Clinical Effectiveness of Vedolizumab in Chinese Ulcerative Colitis Patients: Results From the VALUE Study
12. S287 Clinical Effectiveness of Vedolizumab in Chinese Crohn's Disease Patients: Results From the VALUE Study
13. S593 First Interim Analysis of Safety and Effectiveness in View Study: A Multicenter, Single-Arm, Prospective, Non-Interventional Study of Vonoprazan in Real-World Clinical Practice in China
14. S594 First Interim Analysis of Safety and Effectiveness on Elderly Patients in View Study: A Multicenter, Single-Arm, Prospective, Non-Interventional Study on Vonoprazan in the Real-World Clinical Practice in China
15. Corrigendum to: “The Role of Colchicine in Different Clinical Phenotypes of Behcet's Disease” [Clin Therapeut 45(2) (2023) 162–176]
16. Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn’s disease
17. Trajectory of fecal lactoferrin for predicting prognosis in ulcerative colitis
18. Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
19. Risk Perception, Acceptance, and Trust of Using Artificial Intelligence in Gastroenterology Practice: Survey from the Asia Pacific Region (Preprint)
20. Prognostic models for predicting postoperative recurrence in Crohn’s disease: a systematic review and critical appraisal
21. Gut Microbiome-Generated Phenylacetylglutamine from Dietary Protein is Associated with Crohn’s Disease and Exacerbates Colitis in Mouse Model Possibly via Platelet Activation
22. Fecal lactoferrin early predicts long‐term outcomes in ulcerative colitis: A post‐hoc analysis of the UNIFI and PURSUIT trials
23. Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease
24. A Novel Serum Metabolomic Panel for the Diagnosis of Crohn’s Disease
25. Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn’s disease: a multi-omics Mendelian randomization study
26. Serum amyloid protein A in inflammatory bowel disease: from bench to bedside
27. A Novel Nomogram Combining Mucus Barrier Index for Predicting Treatment Failures in Ulcerative Colitis
28. The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms
29. Bile acid alterations associated with indolent course of inflammatory bowel disease
30. Mucosa-Associated Oscillospira sp. Is Related to Intestinal Stricture and Post-Operative Disease Course in Crohn’s Disease
31. Blocking Dectin-1 prevents colorectal tumorigenesis by suppressing prostaglandin E2 production in myeloid-derived suppressor cells and enhancing IL-22 binding protein expression
32. Cellular and Molecular Mechanisms of Intestinal Fibrosis
33. Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis
34. 111 - EFFICACY AND SAFETY OF UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS FROM A RANDOMIZED PHASE 3 U- EXCEL STUDY
35. 114 - EFFICACY AND SAFETY OF UPADACITINIB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS FROM A RANDOMIZED PHASE 3 U- ENDURE MAINTENANCE STUDY
36. CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn's disease: a multicentre cohort study
37. The Role of Colchicine in Different Clinical Phenotypes of Behcet Disease
38. A nomogram incorporating ileal and anastomotic lesions separately to predict the long-term outcome of Crohn’s disease after ileocolonic resection
39. Platelet-to-Lymphocyte Percentage Ratio (PLpR) for Assessing Disease Activity and Predicting Therapeutic Outcomes in Ulcerative Colitis
40. Early transmural healing and its predictors assessed by magnetic resonance enterography in patients with Crohn’s disease receiving ustekinumab
41. Neutrophil-to-lymphocyte ratio for predicting postoperative recurrence in Crohn’s disease patients with isolated anastomotic lesions
42. Gastrointestinal injury induced by immunomodulators: A review article
43. Ulcerative colitis increases risk of hypertension in a UK biobank cohort study
44. Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study
45. S37 Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Crohn’s Disease: U-ENDURE Phase 3 Results
46. Corticosteroids and Mesalamine Versus Corticosteroids for Acute Severe Ulcerative Colitis: A Randomized Controlled Trial
47. Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association
48. S817 The Effect of Guselkumab Induction Therapy on Inflammatory Biomarkers in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Results Through Week 12
49. S736 Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Crohn’s Disease: Results From a Randomized Phase 3 U-EXCEL Study
50. Clinical implications of immune checkpoint markers and immune infiltrates in patients with thymic neuroendocrine neoplasms
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.